Johnson & Johnson (J&J) was heavily criticized when it hired BroadSpire Services Inc. to handle the DePuy hip replacement recall.  Some critics claimed that to cut down on the expenses entailed in facing all complaints filed following the recall, DePuy is outsourcing the handling of the recall. J&J claimed that the recall will not have a material adverse effect on its finances; however, this may not be the case anymore with some artificial joint manufacturers talking of offshoring in wake of ...
Continue reading ...

About four hundred complaints were received by the United States Food and Drugs Administration regarding the apparent adverse effects DePuy's ASR XL Acetabular System and ASR Hip Resurfacing System inflicts upon recipients resulting in the hip replacement recall. A series of studies conducted by foreign joint registries then prompted DePuy Orthopaedics to recall their products. Now, it would seem that the FDA is taking independent action to address adverse event reports that they have receiv...

Continue reading ...